Tag: Chelsea Pratt
December 10, 2018
Genetics Outlook 2019: CRISPR Technology Advances
With 2018 coming to a close, here's a look at the biggest genetics trends of the year and what's in...
November 25, 2018
What is In-licensing?
In-licensing may be pharma’s preferred mode of business development these days. Should that impact your investment strategy?
November 13, 2018
CRISPR Trials to Watch in 2018
CRISPR Cas-9 gene editing is finally in clinical studies. Here's an overview of CRISPR genetics testing trials currently in progress.
October 14, 2018
10 Drugs Going Off Patent in 2018
A look at 10 drugs going off patent in 2018, plus an overview of what loss of exclusivity means for...
April 29, 2018
5 Top Weekly NASDAQ Biotech Stocks: Eleven Biotherapeutics Up 45 Percent
Eleven Biotherapeutics, EyePoint Pharmaceuticals, Avid Bioservices, Cerecor and Celldex were last week's top gainers on the NASDAQ.
April 4, 2018
6 ASX Medical Device Stocks
These companies are engaged in a wide range of compelling research around everything from respiratory devices and inflatable tissue to...
April 1, 2018